Lupin Gets Tentative Approval From FDA for Combination AIDS Drug

Lupin Ltd., the world’s largest maker of anti-tuberculosis medicines, received tentative approval from the U.S. Food and Drug Administration for its combination AIDS drug containing lamivudine and zidovudine, according to a statement on the regulator’s website.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE